Pharmaceutical giants Eli Lilly and Company & Novo Nordisk A/S face challenges in the obesity market despite promising data.

Chicago drummer Lily Glick Finnegan and New York violinist gabby fluke-mogul throw it in the sink at this weekend’s Catalytic ...

Yes, this is a minor inconvenience, considering the devastation that has occurred in so many areas after two hurricanes. That ...

Eli Lilly & Co. Inc.’s stock LLY rose 2.3% Wednesday, after the company said its Zepbound weight-loss drug was more effective ...

Drugmaker Eli Lilly is claiming victory in the battle of weight loss drugs, now one of the most competitive and lucrative ...

Of late I have been experiencing a reversal of roles in my daily life. The onset of the current phase actually began in 2007 ...

Eli Lilly said its weight loss drug Zepbound led to 47% greater weight reduction than rival medicine Wegovy, made by Novo ...

The U.S. military has strived over recent decades to present itself as religiously diverse, welcoming personnel of all faiths ...

A new study is shedding light on which of two drugs currently approved by the U.S. Food and Drug Administration for weight ...

Astronomers using the James Webb Space Telescope report the discovery of a planet orbiting within the habitable zone of ...

The Alliance for Pharmacy Compounding rebutted Novo's FDA petition to bar compounding pharmacies from copying its weight loss ...

Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical ...